Regevion exists because we got tired of watching peptide science get flattened into hype. So we built the thing we wished existed: every compound paired with the actual study behind it.
Corneliu Giurgea's Fundamentals to a Pharmacology of the Mind set our founder on a four-decade study of peptides — long before "biohacking" was a word anyone used. What started as a personal research obsession slowly became a conviction: this information deserved to exist somewhere honest.
Regevion is that conviction, built into a company. We're not the first peptide brand, and we won't pretend to be the loudest one. We just try to be the one that shows its work.
If we can't point you to the actual study, we don't make the claim. That's not a tagline, it's the editorial rule behind every page in our library.
Some compounds have decades of human trials behind them. Others have promising animal data and not much else. We tell you which is which, every time.
Research-use disclosures live on every page, not buried in fine print. We'd rather lose a sale than mislead someone about what they're buying.
Everything sold on this site is intended for laboratory and research use only — not for human consumption, and not evaluated by the FDA to diagnose, treat, cure, or prevent any disease. We're a research and education company, not a pharmacy or a clinic, and nothing here should be read as medical advice.